We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
From hype to mothballs in four years: troubles in the development of large-scale DNA biobanks in Europe.
- Authors
Rose, Hilary
- Abstract
This paper analyses the difficulties experienced by three large European DNA biobanks. The first, Icelandic-based deCode, generated immense commercial interest and intense ethical controversy. As a biotechnology company, deCode succeeded, but the Icelandic Health Sector Data Base failed. The second firm, Swedish UmanGenomics, marketed itself as the 'ethical' biotech company. Management problems including the inadequate recognition of intellectual property issues led to the company failing to secure adequate investment. The third and largest, UK Biobank, has, as a non-profit organization, not experienced these problems. But when the product - bio information--is marketed, the issue of ethically acceptable purchasers could well become contentious.
- Publication
Community genetics, 2006, Vol 9, Issue 3, p184
- ISSN
1422-2795
- Publication type
Journal Article
- DOI
10.1159/000092655